Literature DB >> 27259564

Cerebellar Mild Iron Accumulation in a Subset of FMR1 Premutation Carriers with FXTAS.

Hailee Rogers1, Jeanelle Ariza1, Angela Monterrubio1, Paul Hagerman2,3, Verónica Martínez-Cerdeño4,5.   

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder associated with premutation alleles of the FMR1 gene. Iron is essential for many facets of cell metabolism in the brain but when altered is likely to contribute to the development of neurodegenerative diseases. We previously reported that iron accumulates in the choroid plexus and the putamen in FXTAS and that the level and distribution of key iron-binding proteins are also altered, suggesting a potential alteration of iron metabolism in the brain. Here, we hypothesize that iron metabolism is also altered in the FXTAS cerebellum. To test this hypothesis, we used cerebellum samples collected from FXTAS and control subjects and measured the amount of iron contained within the cerebellar cortex and dentate nucleus. We found that the number of iron deposits increased in the cerebellum only in a subset of cases of FXTAS. This accumulation is likely to be mediated by factors other than or in addition to CGG-repeat coupled pathology. Thus, iron deposition in the cerebellum cannot be used as a hallmark of FXTAS pathogenesis.

Entities:  

Keywords:  FXTAS; Fragile X tremor ataxia; Purkinje cells; cerebellum; human; iron

Mesh:

Substances:

Year:  2016        PMID: 27259564      PMCID: PMC5014668          DOI: 10.1007/s12311-016-0798-5

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  10 in total

1.  Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS).

Authors:  C M Greco; R F Berman; R M Martin; F Tassone; P H Schwartz; A Chang; B D Trapp; C Iwahashi; J Brunberg; J Grigsby; D Hessl; E J Becker; J Papazian; M A Leehey; R J Hagerman; P J Hagerman
Journal:  Brain       Date:  2005-12-05       Impact factor: 13.501

Review 2.  Iron status and neural functioning.

Authors:  John L Beard; James R Connor
Journal:  Annu Rev Nutr       Date:  2003-04-10       Impact factor: 11.848

3.  Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor/ataxia syndrome.

Authors:  Jeanelle Ariza; Craig Steward; Flora Rueckert; Matt Widdison; Robert Coffman; Atiyeh Afjei; Stephen C Noctor; Randi Hagerman; Paul Hagerman; Verónica Martínez-Cerdeño
Journal:  Brain Res       Date:  2014-12-09       Impact factor: 3.252

Review 4.  Iron deficiency alters brain development and functioning.

Authors:  John Beard
Journal:  J Nutr       Date:  2003-05       Impact factor: 4.798

5.  Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers.

Authors:  C M Greco; R J Hagerman; F Tassone; A E Chudley; M R Del Bigio; S Jacquemont; M Leehey; P J Hagerman
Journal:  Brain       Date:  2002-08       Impact factor: 13.501

Review 6.  Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment.

Authors:  Mark A Smith; Xiongwei Zhu; Massimo Tabaton; Gang Liu; Daniel W McKeel; Mark L Cohen; Xinglong Wang; Sandra L Siedlak; Barney E Dwyer; Takaaki Hayashi; Masao Nakamura; Akihiko Nunomura; George Perry
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 7.  Iron and neurodegeneration: from cellular homeostasis to disease.

Authors:  Liliana Batista-Nascimento; Catarina Pimentel; Regina Andrade Menezes; Claudina Rodrigues-Pousada
Journal:  Oxid Med Cell Longev       Date:  2012-05-30       Impact factor: 6.543

8.  Current Gaps in Understanding the Molecular Basis of FXTAS.

Authors:  Paul J Hagerman
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2012-05-18

Review 9.  Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.

Authors:  Randi J Hagerman; Deborah A Hall; Sarah Coffey; Maureen Leehey; James Bourgeois; John Gould; Lin Zhang; Andreea Seritan; Elizabeth Berry-Kravis; John Olichney; Joshua W Miller; Amy L Fong; Randall Carpenter; Cathy Bodine; Louise W Gane; Edgar Rainin; Hillary Hagerman; Paul J Hagerman
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

Review 10.  Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegeneration.

Authors:  Scott Ayton; Peng Lei
Journal:  Biomed Res Int       Date:  2014-01-16       Impact factor: 3.411

  10 in total
  11 in total

1.  Microglial cell activation and senescence are characteristic of the pathology FXTAS.

Authors:  Verónica Martínez Cerdeño; Tiffany Hong; Sarwat Amina; Mirna Lechpammer; Jeanelle Ariza; Flora Tassone; Stephen C Noctor; Paul Hagerman; Randi Hagerman
Journal:  Mov Disord       Date:  2018-12-10       Impact factor: 10.338

Review 2.  [Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment].

Authors:  M J Salcedo-Arellano; R J Hagerman; V Martinez-Cerdeno
Journal:  Rev Neurol       Date:  2019-03-01       Impact factor: 0.870

3.  A Novel Clinical Phenotype of Fragile X-Associated Tremor/Ataxia Syndrome.

Authors:  Gary Alvarez Bravo; Jose Manuel Fernández-Carril; Ignacio López-Zuazo; Antonio Yusta Izquierdo; Tapan Abrol; Omar Alsinaidi
Journal:  Mov Disord Clin Pract       Date:  2018-07-19

4.  Iron accumulation and dysregulation in the putamen in fragile X-associated tremor/ataxia syndrome.

Authors:  Jeanelle Ariza; Hailee Rogers; Anna Hartvigsen; Melissa Snell; Michael Dill; Derek Judd; Paul Hagerman; Verónica Martínez-Cerdeño
Journal:  Mov Disord       Date:  2017-02-24       Impact factor: 10.338

Review 5.  Fragile X syndrome and associated disorders: Clinical aspects and pathology.

Authors:  Maria Jimena Salcedo-Arellano; Brett Dufour; Yingratana McLennan; Veronica Martinez-Cerdeno; Randi Hagerman
Journal:  Neurobiol Dis       Date:  2020-01-10       Impact factor: 7.046

6.  Rapidly Progressing Neurocognitive Disorder in a Male with FXTAS and Alzheimer's Disease.

Authors:  Elber Yuksel Aydin; Andrea Schneider; Dragana Protic; Jun Yi Wang; Veronica Martínez-Cerdeño; Flora Tassone; Hiu-Tung Tang; Susan Perlman; Randi J Hagerman
Journal:  Clin Interv Aging       Date:  2020-02-26       Impact factor: 4.458

Review 7.  Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications.

Authors:  Ana Maria Cabal-Herrera; Nattaporn Tassanakijpanich; Maria Jimena Salcedo-Arellano; Randi J Hagerman
Journal:  Int J Mol Sci       Date:  2020-06-20       Impact factor: 5.923

Review 8.  Fragile X Premutation: Medications, Therapy and Lifestyle Advice.

Authors:  Deepika Kour Sodhi; Randi Hagerman
Journal:  Pharmgenomics Pers Med       Date:  2021-12-29

9.  Presence of Middle Cerebellar Peduncle Sign in FMR1 Premutation Carriers Without Tremor and Ataxia.

Authors:  Jessica L Famula; Forrest McKenzie; Yingratana A McLennan; James Grigsby; Flora Tassone; David Hessl; Susan M Rivera; Veronica Martinez-Cerdeno; Randi J Hagerman
Journal:  Front Neurol       Date:  2018-08-22       Impact factor: 4.003

10.  Increased iron content in the heart of the Fmr1 knockout mouse.

Authors:  Karo Talvio; Katja M Kanninen; Anthony R White; Jari Koistinaho; Maija L Castrén
Journal:  Biometals       Date:  2021-06-05       Impact factor: 2.949

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.